Therapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter-related infection treated with amikacin.

Sanae Kojya,Hideo Shiohira,Yoshitsugu Sunagawa,Shoji Tsuneyoshi,Kentaro Kohagura, Yusuke Ohya, Fusako Yonaha, Nobuo Hokama,Katsunori Nakamura

Clinical case reports（2020）

引用 2|浏览0

暂无评分

摘要

The pharmacokinetics of amikacin makes it difficult to predict the appropriate dosing to avoid harmful side effects in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The implementation of therapeutic drug monitoring may be useful in controlling amikacin serum concentrations in patients receiving CAPD.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要